The results (Figure 2A) confirmed that all three markers were, to a varying degree, expressed on primary breast cancer cells, thus, indicating inter-patient variations in cell surface marker expression, even within the EpCAM positive population. This evidence concerns the gene EPCAM and breast cancer.